Bid Price | 1997.00p | High Price | 2000.00p |
---|
Ask Price | 2000.00p | Low Price | 1974.00p |
---|
Open Price | 1989.00p | Spread | 0.15% |
---|
Prev Close | 1988.00p | Volume | 387,165 |
---|
Hikma Pharmaceuticals PLC Historic Prices
Date | Open | High | Low | Close | Volume |
---|
Dec 23, 2024 | 1938.00 | 1988.40 | 1932.00 | 1988.00 | 250,173 |
Dec 20, 2024 | 1932.00 | 1959.13 | 1918.00 | 1953.00 | 843,155 |
Dec 19, 2024 | 1915.00 | 1935.00 | 1909.00 | 1935.00 | 328,984 |
Dec 18, 2024 | 1924.00 | 1931.00 | 1906.00 | 1928.00 | 395,209 |
More Hikma Pharmaceuticals PLC Historic Prices >Hikma Pharmaceuticals PLC Information
Name | Hikma Pharmaceuticals PLC | Index | FTSE 100 |
---|
ISIN | GB00B0LCW083 | Epic | HIK |
---|
Type | Equity | Currency | GBX |
---|
Record Status | Active | Trading Segment | SET1 |
---|
Industry | Drug Manufacturers - Specialty & Generic | Sector | Healthcare |
---|
EMS | 500 | Trading Status | Closed |
---|
Shares in Issue | 221.89 m | Prev Close | 1988.00p |
---|
PE Ratio | 29.396682 | Market Cap | £4.41 bn |
---|
Div Yield | 3.1 | Div per Share | $0.25 |
---|
EPS | $0.26 | Div Cover | 1.0288 |
---|
PEG | n/a | EPS Growth (%) | 0.00 |
---|
ROCE | 0.022281 | DPS Growth (%) | 0.1711 |
---|
Current Ratio | 1.568335 | Quick Ratio | 0.760269 |
---|
Hikma Pharmaceuticals PLC Director Deals
Declared | Type | Director | Pos. | Volume / Price | Value |
---|
24/09/24 | DRIP | Riad Mishlawi | CEO | 509 @ £19.03 | £9,686.00 |
09/05/24 | DRIP | Riad Mishlawi | CEO | 736 @ £19.79 | £14,565.00 |
13/03/24 | TIN | Mazen Darwazah | CH | 26,812 @ £0.00 | £0.00 |
13/03/24 | TIN | Mazen Darwazah | CH | 13,903 @ £0.00 | £0.00 |
13/03/24 | TIN | Said Darwazah | CEO | 34,652 @ £0.00 | £0.00 |
13/03/24 | TIN | Said Darwazah | CEO | 19,830 @ £0.00 | £0.00 |
13/03/24 | TIN | Riad Mishlawi | CEO | 22,099 @ £0.00 | £0.00 |
13/03/24 | TIN | Riad Mishlawi | CEO | 17,120 @ £0.00 | £0.00 |
08/06/23 | BUY | Douglas Hurt | NED | 1,500 @ £18.20 | £27,300.00 |
24/04/23 | TIN | Mazen Darwazah | CH | 18,831 @ £0.00 | £0.00 |
More Hikma Pharmaceuticals PLC Director Deals >Hikma Pharmaceuticals PLC News